Skip to main content
. 2021 Nov 19;11:772530. doi: 10.3389/fonc.2021.772530

Figure 3.

Figure 3

Example of a male patient with bone and lymph node metastases from castration-resistant prostate cancer who underwent bone scintigraphy (A) and 18F-DCFPyL (B) and 18F-FDHT PET (C) for research purposes. Bone scintigraphy demonstrated several rib metastases. A large number of additional (measurable) bone metastases were observed on 18F-DCFPyl PET, with additional lymph node metastases detected on-par. Disconcordant AR-expression visualized on 18F-FDHT PET.